Header Logo

Connection

PETER LIN to Cyclopropanes

Back to Details
This is a "connection" page, showing publications PETER LIN has written about Cyclopropanes.
PETER LIN
Connection Strength
0.020
Cyclopropanes
  1. Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells. Atherosclerosis. 2010 Jan; 208(1):104-11.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.